Director Robert Mark Pickering of Marex Group Ltd filed a Form 144 notice on November 12, 2026, proposing the sale of 29,696 ordinary shares through broker Coutts & Co on NASDAQ.

Key Highlights

  • Proposed seller: Robert Mark Pickering, identified in the filing as a Director of Marex Group Ltd.
  • Shares proposed for sale: 29,696 ordinary shares, with an aggregate market value listed as $2,195,425.00.
  • Shares outstanding: 72,466,052 ordinary shares outstanding, according to the filing.
  • Approximate sale date: November 12, 2026, via broker Coutts & Co, 440 Strand, London.
  • Acquisition history: Securities were acquired through a combination of an IPO purchase, open-market purchases, and vesting of restricted stock units between April 2024 and June 2026.
  • No sales in past 3 months: The filing indicates "Nothing to Report" for securities sold during the past 3 months.

Robert Mark Pickering's Proposed Share Sale at Marex Group

According to the Form 144 notice filed with the U.S. Securities and Exchange Commission, Robert Mark Pickering, a Director of Marex Group Ltd (NASDAQ:MRX), proposed to sell 29,696 ordinary shares with an approximate sale date of November 12, 2026. The filing lists the aggregate market value of the shares to be sold as $2,195,425.00. The broker named in the filing is Coutts & Co, located at 440 Strand, London. Marex Group Ltd is listed with SEC File Number 001-42020 and is headquartered at Crawford House, 50 Cedar Avenue, Hamilton, Bermuda.

The filing details six separate acquisition transactions underlying the shares to be sold. Pickering acquired 7,894 ordinary shares through a purchase in the IPO from the issuer on April 25, 2024, paid in cash. He subsequently purchased 5,000 shares in an open-market transaction on August 30, 2024, and another 5,000 shares on October 24, 2024, also in open-market purchases. On August 15, 2025, he acquired 2,700 additional shares through an open-market purchase. Two tranches were received through vesting of restricted stock units: 6,315 shares vested on November 10, 2025, and 2,787 shares vested on June 1, 2026, both listed as employee compensation from the issuer.

The filing states "Nothing to Report" for securities of the issuer sold by Pickering during the past 3 months. The notice was signed by Scott Linsley as Attorney-in-Fact for Robert Mark Pickering, and the date of notice is recorded as November 12, 2026.

What Was Disclosed

Marex Group Ltd Director Robert Mark Pickering filed a Form 144 notice proposing the sale of 29,696 ordinary shares on NASDAQ, with an aggregate market value of $2,195,425.00, acquired through IPO purchase, open-market purchases, and RSU vestings between 2024 and 2026.